Introduction
Panayiotopoulos syndrome (PS) is a ''benign age-related focal seizure disorder occurring in early and mid childhood. It is characterized by seizures, often prolonged, with predominantly autonomic symptoms, and by an EEG that shows shifting and/or multiple foci, often with occipital predominance''.
1,2 Autonomic seizures in PS consist of episodes characterized by emetic symptoms usually accompanied by other autonomic features (colour changes, especially pallor, pupillary changes, cardiorespiratory and thermoregulatory alterations) and more conventional ictal clinical manifestations such as unilateral deviation of the eyes and convulsions. 1,2 PS starts at a peak age of 3-6 years, with no apparent sex or race prevalence, and affects about 6% of children with seizures aged 1-15 years. 3 An increased rate of febrile seizures is reported in patients with PS 3 ; also, it has been reported that in patients with PS, autonomic seizures can occur during a febrile illness. 4, 5 In these patients, mutations of the sodium channel, voltage-gated, type I, alpha subunit gene (SCN1A) have been found. The aim of the present study is to examine the role of fever as a triggering factor for autonomic seizures in patients with PS, and to evaluate the pathogenetic role of SCN1A gene in PS patients with seizures triggered by fever.
Patients and methods
The medical records of patients referred to the Child Neurology and Psychiatry Unit of S. Orsola-Malpighi Hospital, Bologna, for seizures from January 2000 to June 2008 were reviewed. All the patients who fulfilled the following diagnostic criteria for Panayiotopoulos syndrome were enrolled in the study: (a) age at the onset of epilepsy from 1 to 14 years; (b) presence of at least one autonomic seizure of unequivocal epileptic origin; (c) normal neurological and mental status; and (d) normal brain imaging. Results: Thirty patients fulfilled the inclusion criteria. Eleven patients (36%) had at least one focal autonomic seizure triggered by fever (group A). In group A, 7/11 patients (63.5%) had the first focal autonomic seizure during a febrile illness. Two of these 7 patients were misdiagnosed at the onset of PS. The median age at the onset of PS was slightly lower in group A than in group B (p = .050). Moreover, patients in group A more frequently had a positive familial history of febrile seizures (FS) (p = .047). No mutations of SCN1A were found in any of the 10 patients screened. Conclusion: Fever is a common trigger for focal autonomic seizures in PS. Knowing that an autonomic manifestation during fever can be an epileptic seizure could facilitate diagnosis and prevent unnecessary investigations and erroneous treatments. Moreover, our data show that SCN1A gene does not contribute significantly to susceptibility to autonomic seizures during fever in patients with PS.
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Patients with paroxysmal autonomic manifestations of nonepileptic origin were excluded. Symptomatic epilepsy and preexisting neurodevelopmental abnormalities were considered as exclusion criteria. EEG features were not considered as inclusion or exclusion criteria due to the current evidence that PS is a multifocal epileptic syndrome with a significant EEG variability. 3 The following data were collected: familial history of seizures; pre-and perinatal antecedents; neurologic development; epileptic history; semiology of seizures; EEG features; brain magnetic resonance imaging (MRI); and treatment. Outcome was assessed only for patients that had 3 years of follow-up.
The patients enrolled were then divided into two groups, according to the presence (group A) or absence (group B) of seizures triggered by fever. For the purpose of this study, a seizure was considered as triggered by fever only if it occurred during a febrile illness of documented origin. Specifically, group A included PS patients who had at least one seizure during febrile illness, while group B included PS patients who had never had seizures triggered by fever.
Demographic variables, familial history of febrile seizures (FS) and/or epilepsy, age at onset, the occurrence of misdiagnosis, secondary generalization, duration of seizures, number of seizures, EEG features at the onset of the disease, therapy with antiepileptic drugs (AEDs) and outcome in the two groups were compared.
In group A, the number of patients who had a focal autonomic seizure during fever at the onset of PS, the rate of focal autonomic seizures during fever, and the etiology of febrile illnesses were also analyzed.
Genetic analysis
In patients of group A, SCN1A mutational screening was performed by denaturing high-performance liquid chromatography (DHPLC) and multiplex ligation probe amplification (MLPA).
The study protocol was approved by the Ethical Committee of S. Orsola-Malpighi Hospital in Bologna (protocol code: PAN 2010, trial no. 37/2010/O/Tess).
Written, informed consent was obtained from the patients' parents or caregivers.
Statistical analysis
Statistical analysis was performed by Statistical Package for the Social Sciences (SPSS) 16.0 (SPSS Inc., Chicago, IL, USA) for Windows. Categorical variables were compared by chi-square test, while continuous variables were compared by MannWhitney test. The level of significance was set at p 0.05.
Results

Demographic and clinical data
Thirty patients (14 males and 16 females) fulfilled the inclusion criteria.
Eleven patients (36%) had at least one focal autonomic seizure triggered by fever, and thus were included in group A; four of these 11 patients had, in addition, one or more seizures triggered by fever described as generalized tonic clonic seizure (GTCS). The remaining 19 patients (64%), who were included in group B, had no history of seizures during febrile illness.
The male/female ratio was comparable between the two groups. No significant difference was found between the two groups regarding: the number of seizures; the occurrence of secondary generalization and of autonomic status epilepticus; EEG features at the onset of disease; the use of AEDs; and outcome.
The median age at the onset of PS was slightly lower in group A than in group B (p = .050). Moreover, patients in group A more frequently had a positive familial history of FS (p = .047), while no differences in familial history of epilepsy were found between the two groups. In group A, 7 patients (63.5%) had their first focal autonomic seizure during a febrile illness. Two of these 7 patients were misdiagnosed at the onset of PS. One patient was diagnosed and treated for febrile gastroenteritis, while the other patient had a febrile autonomic status at the onset simulating encephalitis and underwent several diagnostic procedures, including a lumbar puncture. Patients in group A had overall 97 focal autonomic seizures, 19 (19.5%) of which occurred during fever. In 16 cases, the fever was due to viral infections (12 upper airway infections, 3 exanthematic diseases, 1 enteritis), while in 3 cases the fever was due to bacterial infections (pneumonia, bronchitis, and otitis).
Genetic analysis
Genetic analysis of SCN1A was performed in 10 out of the 11 patients included in group A (the parents of one patient did not give their consent to DNA analysis). No mutation was found in any of the patients.
Results are summarized in Table 1 .
Discussion
Fever is currently not considered a seizure precipitant factor in PS. However, an increased rate of febrile seizures 3 and isolated cases of PS associated with SCN1A mutations have been recently reported. 4, 5 This is the first attempt to investigate the relationship between fever and PS in a large and selected population. Our study shows that fever is a common seizure precipitant factor in PS: in our cohort, we found that 36% of the patients had at least one focal autonomic seizure triggered by fever.
Thermoregulatory alterations are possible autonomic manifestations of seizures in patients with PS 6, 7 ; to reduce misinterpretations, we considered a seizure to be triggered by fever only if it occurred during a febrile illness of documented origin. PS is often misdiagnosed at onset because emetic and other autonomic manifestations are not recognized as seizure events. Autonomic symptoms may suggest nonepileptic conditions, such as atypical migraine, gastroenteritis, syncope, encephalitis, or intoxication. 8 Our experience suggests that misdiagnosis is more likely if autonomic seizures occur during fever. Seven of our patients had their first focal autonomic seizure during a febrile illness, and 2 of those 7 patients were misdiagnosed with febrile gastroenteritis and encephalitis. We believe that considering epileptic seizures in the differential diagnosis of autonomic manifestations during fever can facilitate early diagnosis of PS and prevent unnecessary investigations and erroneous treatments. The epilepsy features and EEG characteristics of our population were comparable with literature data. 9, 10 The median age at the onset of PS was slightly lower in the patients of group A. This could suggest a higher, age-related, predisposition to seizures triggered by fever in patients with early onset of PS. Furthermore, we found that patients in group A more frequently had a positive familial history of FS, supporting the hypothesis of a genetically based higher predisposition to seizures triggered by fever. For this reason and following recent reports, 4, 5 we performed the analysis of SCN1A gene in patients with a history of at least one seizure during fever.
Our data show that SCN1A gene does not contribute significantly to susceptibility to autonomic seizures during fever in patients with PS. Therefore, we advise against routine screening for SCN1A mutations in patients with focal autonomic seizures triggered by fever.
Conclusion
Our data show that fever is a common trigger for focal autonomic seizures in PS. Knowing that an autonomic manifestation during fever can be an epileptic seizure could facilitate diagnosis and prevent unnecessary investigations and erroneous treatments. Moreover, SCN1A gene does not seem to contribute significantly to autonomic seizures susceptibility during fever in patients with PS. However, more studies are needed to better understand the complex genetic background of PS. 
